Literature DB >> 17016644

Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells.

Tomitaro Onoue1, Daisuke Uchida, Nasima Mila Begum, Yoshifumi Tomizuka, Hideo Yoshida, Mitsunobu Sato.   

Abstract

Epithelial-mesenchymal transition (EMT) refers to critical events occasionally observed during tumor progression, including invasion and metastasis, by which cancer cells acquire a fibroblast-like phenotype. Since the stromal cell-derived factor-1 (SDF-1)/CXCR4 system can facilitate lymph node metastasis in oral squamous cell carcinoma (SCC), we have explored the possibility that this system might be involved in EMT. Oral SCC cells, B88 and HNt, which have functional CXCR4 and lymph node metastatic potential, were found to lose their epithelial cell morphology due to SDF-1. In this context, the downregulation of epithelial markers, cytokeratin, E-cadherin and beta-catenin, and the upregulation of mesenchymal marker, vimentin and snail were detected. Furthermore, upregulation of vimentin by treatment with SDF-1 was impaired by phosphatidylinositol 3 kinase (PI3K) inhibitor Wortmannin, but not by mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor U0126. In the type I collagen embedding culture, SDF-1-treated B88 cells formed protruding extensions, but the effect was impaired by treatment with Wortmannin. These results suggested that EMT induced by the SDF-1/CXCR4 system might be involved in the lymph node metastasis of oral SCCs via activation of PI3K-Akt/PKB pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016644

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  54 in total

Review 1.  Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.

Authors:  Xiao-hong Yao; Ying Liu; Keqiang Chen; Wanghua Gong; Ming-yong Liu; Xiu-wu Bian; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-09-17       Impact factor: 4.932

2.  CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.

Authors:  Nozomu Sakai; Hiroyuki Yoshidome; Takashi Shida; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Dan Takeuchi; Masahiro Sakakibara; Masaru Miyazaki
Journal:  Clin Exp Metastasis       Date:  2011-11-11       Impact factor: 5.150

3.  The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.

Authors:  Jieer Ying; Qi Xu; Gu Zhang; Bixia Liu; Liming Zhu
Journal:  Med Oncol       Date:  2011-06-01       Impact factor: 3.064

Review 4.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

5.  JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Anbing Dong; Jianpeng Fan; Kejian Guo; Yuanhong Xu
Journal:  Tumour Biol       Date:  2012-04-27

6.  Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma.

Authors:  Marcus Franz; Karin Spiegel; Claudia Umbreit; Petra Richter; Carolina Codina-Canet; Angela Berndt; Annelore Altendorf-Hofmann; Sven Koscielny; Peter Hyckel; Hartwig Kosmehl; Ismo Virtanen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2009-02-06       Impact factor: 4.304

7.  Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis.

Authors:  Sorachai Srisuma; Soumyaroop Bhattacharya; Dawn M Simon; Siva K Solleti; Shivraj Tyagi; Barry Starcher; Thomas J Mariani
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

8.  Human nephrosclerosis triggers a hypoxia-related glomerulopathy.

Authors:  Matthias A Neusser; Maja T Lindenmeyer; Anton G Moll; Stephan Segerer; Ilka Edenhofer; Kontheari Sen; Daniel P Stiehl; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff; Clemens D Cohen
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  Expression and function of CXCR4 in human salivary gland cancers.

Authors:  Daisuke Uchida; Nobuyuki Kuribayashi; Makoto Kinouchi; Go Ohe; Tetsuya Tamatani; Hirokazu Nagai; Youji Miyamoto
Journal:  Clin Exp Metastasis       Date:  2012-07-31       Impact factor: 5.150

10.  Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.

Authors:  Muzafar A Macha; Nissar A Wani; Rais A Ganai; Ajaz A Bhat; Abid Hamid; Sheema Hashem; Mohammad Haris; Sham S Chauhan; Mohammad A Zargar; Surinder K Batra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.